Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

High levels of troponin T are associated with ventricular remodeling and adverse in-hospital outcome in heart failure.

Perna ER, Macín SM, Cimbaro Canella JP, Alvarenga PM, Pantich RE, Ríos NG, Cialzeta JR, Farías EF, Badaracco JR, Brizuela M, Jantus E, Missov ED.

Med Sci Monit. 2004 Mar;10(3):CR90-5.

PMID:
14976458
2.

Ongoing myocardial injury in stable severe heart failure: value of cardiac troponin T monitoring for high-risk patient identification.

Perna ER, Macin SM, Canella JP, Augier N, Stival JL, Cialzeta JR, Pitzus AE, Garcia EH, Obregón R, Brizuela M, Barbagelata A.

Circulation. 2004 Oct 19;110(16):2376-82.

3.

Cardiac troponin T vs other biochemical markers in patients with congestive heart failure.

Nishio Y, Sato Y, Taniguchi R, Shizuta S, Doi T, Morimoto T, Kimura T, Kita T.

Circ J. 2007 May;71(5):631-5.

4.

Implications of elevated cardiac troponin T in ambulatory patients with heart failure: a prospective analysis.

Hudson MP, O'Connor CM, Gattis WA, Tasissa G, Hasselblad V, Holleman CM, Gaulden LH, Sedor F, Ohman EM.

Am Heart J. 2004 Mar;147(3):546-52.

PMID:
14999208
5.

Cardiac troponin I as diagnostic and prognostic marker in severe heart failure.

La Vecchia L, Mezzena G, Zanolla L, Paccanaro M, Varotto L, Bonanno C, Ometto R.

J Heart Lung Transplant. 2000 Jul;19(7):644-52.

PMID:
10930813
6.

[Differences in clinical profile and outcome in patients with decompensated heart failure and systolic dysfunction or preserved systolic function].

Macín SM, Perna ER, Címbaro Canella JP, Alvarenga P, Pantich R, Ríos N, Farías EF, Badaracco JR.

Rev Esp Cardiol. 2004 Jan;57(1):45-52. Spanish.

7.

[Heart fatty acid binding protein in patients hospitalized because of worsening heart failure. Relation to prognosis of death].

Mazovets OL, Trifonov IR, Katrukha AG, Bereznikova AV, Medvedeva MV, Deev AD, Gratsianksiĭ NA.

Kardiologiia. 2008;48(1):24-9. Russian.

PMID:
18260992
8.

Heart-type fatty acid-binding protein is more sensitive than troponin T to detect the ongoing myocardial damage in chronic heart failure patients.

Niizeki T, Takeishi Y, Arimoto T, Takabatake N, Nozaki N, Hirono O, Watanabe T, Nitobe J, Harada M, Suzuki S, Koyama Y, Kitahara T, Sasaki T, Kubota I.

J Card Fail. 2007 Mar;13(2):120-7.

PMID:
17395052
9.

Tumour Necrosis Factor alpha and Troponin T as predictors of poor prognosis in patients with stable heart failure.

Rodríguez-Reyna TS, Arrieta O, Castillo-Martínez L, Orea-Tejeda A, Guevara P, Rebollar V, Granados J.

Clin Invest Med. 2005 Feb;28(1):23-9.

PMID:
15770879
10.

Cardiac troponin and outcome in acute heart failure.

Peacock WF 4th, De Marco T, Fonarow GC, Diercks D, Wynne J, Apple FS, Wu AH; ADHERE Investigators..

N Engl J Med. 2008 May 15;358(20):2117-26. doi: 10.1056/NEJMoa0706824.

11.

Cardiac troponin T as a prognostic marker in patients with heart failure : a 3-year outcome study.

Demir M, Kanadasi M, Akpinar O, Dönmez Y, Avkarogullari M, Alhan C, Inal T, San M, Usal A, Demirtas M.

Angiology. 2007 Oct-Nov;58(5):603-9.

PMID:
18024945
12.

Prognostic factors and predictors of in-hospital mortality of patients with heart failure with preserved left ventricular ejection fraction.

Pérez de Isla L, Zamorano J, Hernández N, Contreras L, Rodrigo JL, Almería C, Aubele AL, Mataix L, Macaya C.

J Cardiovasc Med (Hagerstown). 2008 Oct;9(10):1011-5. doi: 10.2459/JCM.0b013e3282fbca87.

PMID:
18799963
13.

Minor myocardial damage is a prevalent condition in patients with acute heart failure syndromes and preserved systolic function with long-term prognostic implications: a report from the CIAST-HF (Collaborative Italo-Argentinean Study on cardiac Troponin T in Heart Failure) study.

Perna ER, Aspromonte N, Cimbaro Canella JP, Di Tano G, Macin SM, Feola M, Coronel ML, Milani L, Parras JI, Milli M, García EH, Valle R.

J Card Fail. 2012 Nov;18(11):822-30. doi: 10.1016/j.cardfail.2012.10.008.

PMID:
23141854
14.

Clinical importance of elevated CK-MB and troponin I levels in congestive heart failure.

Yilmaz A, Yalta K, Turgut OO, Yilmaz MB, Ozyol A, Kendirlioglu O, Karadas F, Tandogan I.

Adv Ther. 2006 Nov-Dec;23(6):1060-7.

PMID:
17276973
15.

Importance of early combined N-terminal pro-brain natriuretic peptide and cardiac troponin T measurements for long-term risk stratification of patients with decompensated heart failure.

Perna ER, Macin SM, Cimbaro Canella JP, Szyszko A, Franciosi V, Vargas Morales W, Bayol AP, Kriskovich JO, Medina F, Gonzalez Arjol B, Brizuela M.

J Heart Lung Transplant. 2006 Oct;25(10):1230-40.

PMID:
17045936
16.

Cardiac troponin T levels are associated with poor short- and long-term prognosis in patients with acute cardiogenic pulmonary edema.

Perna ER, Macín SM, Parras JI, Pantich R, Farías EF, Badaracco JR, Jantus E, Medina F, Brizuela M.

Am Heart J. 2002 May;143(5):814-20.

PMID:
12040342
17.

Serum cardiac troponin T in patients hospitalized with heart failure is associated with left ventricular hypertrophy and systolic dysfunction.

Löwbeer C, Gustafsson SA, Seeberger A, Bouvier F, Hulting J.

Scand J Clin Lab Invest. 2004;64(7):667-76.

PMID:
15513324
18.

Prognostic value of troponin T and homocysteine in patients with end-stage renal disease.

Sahinarslan A, Güz G, Okyay K, Mutluay R, Yalçin R, Bali M, Sindel S, Cengel A.

Turk Kardiyol Dern Ars. 2008 Sep;36(6):382-7.

19.

[The determination of the factors impacting on in-hospital mortality in patients with acute heart failure in a tertiary referral center].

Zoghi M, Duygu H, Güngör H, Nalbantgil S, Yilmaz GM, Tülüce K, Ozerkan F, Akilli A, Akin M.

Anadolu Kardiyol Derg. 2008 Aug;8(4):255-9. Turkish.

20.
Items per page

Supplemental Content

Support Center